Showing results (251-260 of 287) with videos related to

Sort By:
Pageof 29
The Pharmacogenomics Journal|July 8, 2015
The -308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritisM Fabris, L Quartuccio, C Fabro, et al.
Aging (Milan, Italy)|February 1, 2002
Tolerability of risedronate in postmenopausal women intolerant of alendronateJ D Adachi, S Adami, P D Miller, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 31, 2007
Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO)C Cooper, F Jakob, C Chinn, et al.
Annals of the Rheumatic Diseases|October 30, 2007
Effects of strontium ranelate on spinal osteoarthritis progressionO Bruyere, D Delferriere, C Roux, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 12, 2012
Osteoporosis in young adults: pathophysiology, diagnosis, and managementS Ferrari, M L Bianchi, J A Eisman, et al.
The Journal of Rheumatology|November 28, 2000
A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid ArthritisL Sinigaglia, A Nervetti, Q Mela, et al.
QJM : Monthly Journal of the Association of Physicians|July 25, 2006
Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO)F Jakob, F Marín, E Martín-Mola, et al.
Annals of the Rheumatic Diseases|March 17, 2004
Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxibH Tannenbaum, F Berenbaum, J-Y Reginster, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 17, 2007
Effect of raloxifene after recombinant teriparatide [hPTH(1-34)] treatment in postmenopausal women with osteoporosisS Adami, J San Martin, M Muñoz-Torres, et al.
Clinical Nephrology|October 1, 1986
Controlled trial of calcitriol in hemodialysis patientsL R Baker, J W Muir, V L Sharman, et al.
Pageof 29